Financial Performance - The company's revenue for Q1 2025 reached ¥176,343,757.34, representing a 41.83% increase compared to ¥124,332,621.75 in the same period last year[4] - Net profit attributable to shareholders was ¥47,417,837.41, a significant increase of 183.24% from ¥16,741,205.71 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥42,553,380.50, up 171.28% from ¥15,686,119.75 in the previous year[4] - The basic and diluted earnings per share both increased by 105.26% to ¥0.39 from ¥0.19[4] - Total operating revenue for the current period reached ¥176,343,757.34, a 42% increase from ¥124,332,621.75 in the previous period[20] - Net profit for the current period was ¥47,417,837.41, compared to ¥16,741,205.71 in the previous period, representing a 183% increase[21] - Basic and diluted earnings per share increased to ¥0.39 from ¥0.19, marking a 105% rise[21] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,313,499,980.56, a 2.21% increase from ¥2,263,389,145.02 at the end of the previous year[4] - Current assets totaled RMB 1,579,764,504.34, up from RMB 1,503,877,958.89, indicating an increase of about 5.5%[17] - Total liabilities stood at RMB 116,704,446.63, slightly up from RMB 114,569,854.99, showing a marginal increase of about 1.9%[18] - The total equity attributable to the parent company reached RMB 2,196,795,533.93, compared to RMB 2,148,819,290.03 at the beginning of the period, reflecting an increase of approximately 2.2%[19] Cash Flow - The company's cash flow from operating activities decreased by 37.98% to ¥46,227,892.04 from ¥74,538,568.94 in the same period last year[4] - Operating cash flow net amount was ¥46,227,892.04, down from ¥74,538,568.94 in the previous period, indicating a decrease of 38%[23] - Cash and cash equivalents at the end of the period totaled ¥239,990,036.73, down from ¥536,014,618.49, a decline of 55%[23] - Investment activities generated a net cash flow of ¥2,528,001.29, a significant recovery from a net outflow of ¥21,447,108.10 in the previous period[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 12,778[10] - Kingchem (China) held 48.66% of the shares, making it the largest shareholder[11] - The total number of restricted shares at the end of the period was 63,705,741, with no changes during the reporting period[14] Expenses - Total operating costs amounted to ¥125,403,640.07, up from ¥110,839,890.09, reflecting a 13% increase[20] - The company's inventory decreased to RMB 175,026,165.78 from RMB 194,971,270.02, indicating a decline of about 10.3%[17] - The non-current assets totaled RMB 733,735,476.22, down from RMB 759,511,186.13, representing a decrease of approximately 3.4%[18] - The company's retained earnings increased to RMB 417,881,637.49 from RMB 370,607,655.09, reflecting a growth of about 12.7%[19] - The company reported a decrease in sales expenses to ¥4,899,774.21 from ¥5,094,051.33, a reduction of 4%[20] - Research and development expenses slightly increased to ¥7,018,049.89 from ¥6,964,404.48, reflecting a growth of 1%[20] Investment Income - The company reported a 111.52% increase in investment income to ¥3,377,328.16, compared to ¥1,596,683.03 in the previous year[9] Other Comprehensive Income - Other comprehensive income after tax showed a loss of ¥512,035.25 compared to a gain of ¥264,604.89 in the previous period[21]
金凯生科(301509) - 2025 Q1 - 季度财报